metastases

You have access
MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy
Sumudu Katugampola, Jianchao Wang and Roger W. Howell

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1965-1973; DOI: https://doi.org/10.2967/jnumed.123.267238
You have access
Association of Free-to-Total PSA Ratio and ¹⁸F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study
Rui M. Bernardino, Katherine Lajkosz, Leyi B. Yin, Rashid K. Sayyid, Marian Wettstein, Harkanwal Randhawa, Jessica G. Cockburn, Sayeed Ahmed, Rosita Thomassian, Eleftherios Diamandis, Ur Metser, Alejandro Berlin and Neil E. Fleshner

Journal of Nuclear Medicine November 1, 2024, 65 (11) 1731-1739; DOI: https://doi.org/10.2967/jnumed.124.267877
You have access
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer
Bertha Eisses, Jasper J.L. van Geel, Adrienne H. Brouwers, Frederike Bensch, Sjoerd G. Elias, Evelien J.M. Kuip, Agnes Jager, Bert van der Vegt, Marjolijn N. Lub-de Hooge, Jasper Emmering, Anne I.J. Arens, Gerben J.C. Zwezerijnen, Daniëlle J. Vugts, C. Willemien Menke-van der Houven van Oordt, Elisabeth G.E. de Vries and Carolina P. Schröder

Journal of Nuclear Medicine October 1, 2024, 65 (10) 1540-1547; DOI: https://doi.org/10.2967/jnumed.124.267636
You have access
Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy
Ghadah Al-Naqeeb, Eric Munger, Amrita L. Ramanathan, Andrew Makarewicz, Noha Behairy, Padmasree Veraraghavan, Craig Cochran, Philip Bernaldez, Iman Clinton, Newbegin Devaraj, Korressa Lee, Teresa Fisher, Olumide Owoade, Roberto Maass-Moreno, Babak Saboury, Sriram Gubbi and Joanna Klubo-Gwiezdzinska

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1336-1339; DOI: https://doi.org/10.2967/jnumed.123.266955
You have access
High Tumor Uptake on ¹⁸F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d’étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Ophélie De Rycke, Marine Perrier, Éric Ouvrard, Clément Mennetrey, Choaib Lachachi, Aurélie Bando-Delaunay, David Morland, Bernard Goichot, David Taieb, Thomas Walter, Guillaume Cadiot, Jérôme Cros, Olivia Hentic, Philippe Ruszniewski, Rachida Lebtahi, Alessio Imperiale and Louis de Mestier

Journal of Nuclear Medicine November 1, 2023, 64 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.123.265584
Open Access
The Added Value of ⁶⁸Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with ¹⁸F-FDG–Negative Findings
Bingxin Gu, Xiaoping Xu, Ji Zhang, Xiaomin Ou, Zuguang Xia, Qing Guan, Silong Hu, Zhongyi Yang and Shaoli Song

Journal of Nuclear Medicine June 1, 2022, 63 (6) 875-881; DOI: https://doi.org/10.2967/jnumed.121.262790
You have access
Rate of Distant Metastases on ¹⁸F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 Years
Vincent Lebon, Jean-Louis Alberini, Jean-Yves Pierga, Véronique Diéras, Nina Jehanno and Myriam Wartski

Journal of Nuclear Medicine February 1, 2017, 58 (2) 252-257; DOI: https://doi.org/10.2967/jnumed.116.178749
You have access
Retrospective Analysis of ¹⁸F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years
Christopher C. Riedl, Elina Slobod, Maxine Jochelson, Monica Morrow, Debra A. Goldman, Mithat Gonen, Wolfgang A. Weber and Gary A. Ulaner

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1578-1583; DOI: https://doi.org/10.2967/jnumed.114.143297

Main menu

User menu

Search

metastases